THE MMRF ANSWER
FUND LAUNCHES TO
ANSWER QUESTIONS
ABOUT YOUR CARE
The MMRF is collecting as much data as possible from our
multiple myeloma patients. This data is stored and collected
from patients who have participated in our Multiple Myeloma
Genomics Initiative (MMGI), our MMRF CoMMpass Study, SM
and other studies, to be used by researchers anywhere in the
world. We are also working with our partners to analyze this
data to help predict which patients respond best to certain
treatments, which could help doctors decide how best to
treat every patient in the future.
But, this data can be used to answer even more questions.
We are investing $5 million over the next three years into
The MMRF Answer Fund, designed to answer the questions
that are most important to the entire myeloma community,
including patients, caregivers, and health care providers as
well as researchers.
THE ANSWER FUND HAS TWO COMPONENTS:
The first part concerns high-risk patients. Despite recent
advances in treatment, some myeloma patients that pass away
within two years of diagnosis; these patients are defined as
“high risk.”
WE NEED TO KNOW:
hich patients are high risk at diagnosis?
W
hat is the best treatment for high risk patients?
W
6
The MMRF has invited researchers to use our data to answer
these two important questions. MMRF will fund studies that
have the best chance of success.
The second part of the Answer Fund asked patients,
caregivers, researchers, and health care providers to tell
us what their most important questions are. Questions
were submitted on our website: TheMMRF.IdeaScale.com.
Participants could also see other submitted questions and
vote on ones they liked. The top questions will be answered
through MMRF-funded research.
T H E M M R F.ORG